市場調查報告書
商品編碼
1597086
北美眼科設備市場預測至 2031 年 - 區域分析 - 按產品、應用和最終用戶North America Ophthalmology Devices Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User |
2023年北美眼科器械市場價值為172.2121億美元,預計到2031年將達到329.590億美元;預計 2023 年至 2031 年複合年成長率為 8.5%。
對眼科護理服務遠距醫療的日益關注推動了北美眼科設備市場
隨著影像擷取和資料傳輸技術的進步,眼科正在大力擁抱遠距醫療整合。隨著智慧型手機和第五代 (G) 無線通訊的快速使用,遠端眼科技術(稱為遠端眼科)的採用迅速發展。遠距眼科可非同步(儲存轉發)和同步(即時)用於眼部疾病的診斷、篩檢、監測和治療,例如老年黃斑部病變、糖尿病視網膜病變、青光眼、神經眼科疾病和小兒眼部疾病,包括早產兒視網膜病變。此外,遠距醫療與眼科的整合在改善篩檢程序和治療的可近性方面具有巨大的潛力。透過這種方法實現的遠端患者監控提高了眼科護理服務的整體品質。遠距醫療和遠距眼科已經存在多年,但在 COVID-19 大流行期間,這些做法變得非常重要。因此,已開發國家和發展中國家遠距眼科的採用預計將在未來幾年為眼科設備市場帶來顯著的成長趨勢。
北美眼科設備市場概況
2023年北美眼科設備市場價值為172.2121億美元,預計2031年將達到329.5900億美元;預計 2023-2031 年複合年成長率為 8.4%。北美眼科設備市場的成長歸因於人口老化的加劇和眼部疾病盛行率的增加。
根據人口資料局2019 年的數據,到2060 年,美國65 歲及以上的人口數量預計將從2018 年的5,200 萬人(佔總人口的16%)增加一倍,達到近9,500 萬(佔總人口的23%)根據美國眼科學會 2019 年的研究,預計到 2050 年,美國將有 732 萬名 70-75 歲的人受到原發性開角型青光眼 (POAG) 的影響。
視力障礙和視力不佳等眼部疾病是美國眼科手術數量激增的主要原因。根據 Starsurgical 2023 年投資人介紹,美國每年進行近 300 萬例屈光手術。眼科設備市場的公司正在採取各種有機和無機成長策略;下面提到了最近發生的一些事例。
2023 年 9 月,OCULUS, Inc. 與 LUVO 合作,在美國驗光和眼科市場推出兩款新型患者治療設備-DARWIN 和 LUCENT。 LUCENT IPL、DARWIN IPL 和 RF 設備旨在為眼科護理人員提供有效且舒適的治療方式,從而針對患者症狀的根本原因。
此外,根據加拿大統計局的估計,到 2036 年,老年人預計將佔加拿大人口的 23-25%,到 2061 年將佔加拿大人口的 24-28%。由於人口老化,眼部疾病的發生率很高。
北美眼科設備市場收入及 2031 年預測(百萬美元)
北美眼科設備市場細分
北美眼科設備市場根據產品、應用、最終用戶和國家進行細分。
根據產品,北美眼科設備市場分為視力保健產品、手術設備以及診斷和監測設備。 2023 年,視力保健產品領域佔最大佔有率。
在應用方面,北美眼科設備市場分為白內障、青光眼、難治性疾病、玻璃體視網膜疾病和其他應用。 2023 年,青光眼細分市場佔最大佔有率。
按最終用戶分類,北美眼科設備市場分為醫院和眼科診所、學術和研究實驗室以及其他最終用戶。 2023 年,醫院和眼科診所佔據最大佔有率。
按國家/地區分類,北美眼科設備市場分為美國、加拿大和墨西哥。 2023年,美國在北美眼科設備市場佔據主導地位。
北美眼科設備市場的主要參與者包括強生視力保健公司、愛爾康公司、卡爾蔡司醫療公司、博士倫公司、依視路Intonational SAS、尼德克有限公司、拓普康公司、Haag-Streit AG、 Ziemer Ophthalmic Systems AG 、和 Hoya Corp 是北美眼科設備市場上的一些領先公司。
The North America ophthalmology devices market was valued at US$ 17,221.21 million in 2023 and is expected to reach US$ 32,959.00 million by 2031; it is estimated to register at a CAGR of 8.5% from 2023 to 2031.
Growing Focus on Telemedicine for Eye Care Services Fuels North America Ophthalmology Devices Market
With technological advancements in image capturing and data transmission, ophthalmology is strongly embracing telehealth integration. The adoption of technology in delivering remote eye care, known as teleophthalmology, has evolved rapidly with the rapid usage of smartphones and 5th generation (G) wireless communications. Teleophthalmology can be used both asynchronously (store-and-forward) and synchronously (real-time) in the diagnosis, screening, monitoring, and treatment of eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma, neuro-ophthalmic disorders, and pediatric ocular diseases, including the retinopathy of prematurity. Moreover, the integration of telehealth in ophthalmology presents strong potential to improve access to screening procedures and treatments. Remote patient monitoring, enabled by this approach, enhances the overall quality of eye care services. Telemedicine and teleophthalmology are already in place since many years, but the practices gained significant importance during the COVID-19 pandemic. Hence, the adoption of teleophthalmology, in both developed and developing countries is expected to bring significant growth trends in the ophthalmology devices market in the coming years.
North America Ophthalmology Devices Market Overview
The North America Ophthalmology Devices market was valued at US$ 17,221.21 million in 2023 and is projected to reach US$ 32,959.00 million by 2031; it is expected to register a CAGR of 8.4% during 2023-2031. The ophthalmology devices market growth in North America is attributed to the rising aging population and the increasing prevalence of eye diseases.
As per the Population Reference Bureau 2019, the number of individuals in the US aged 65 and older is estimated to double from 52 million (16% of the total population) in 2018 to nearly 95 million (23% of the total population) by 2060. As per the American Academy of Ophthalmology's 2019 study, an estimated 7.32 million people aged 70-75 would be affected by primary open-angle glaucoma (POAG) in the US by 2050.
Eye conditions such as vision impairment and poor vision are the prominent causes of a surging number of eye surgeries in the US. According to the 2023 investors' presentation of Starsurgical, nearly 3000,000 refractive procedures are performed in the US every year. Companies in the ophthalmology devices market are adopting various organic and inorganic growth strategies; a few of the recent instances are mentioned below.
In September 2023, OCULUS, Inc. partnered with LUVO to introduce two new patient treatment devices-the DARWIN and LUCENT-in the US optometry and ophthalmology market. The LUCENT IPL, and DARWIN IPL and RF devices are intended to offer eye care practitioners effective and comfortable treatment modalities that can target the root causes of patient symptoms.
Furthermore, according to the Statistics Canada estimates, seniors are expected to comprise ~23-25% of the Canadian population by 2036 and ~24-28% of the population by 2061. The rising geriatric population is expected to propel the adoption of ophthalmology devices as the aging population is highly prone to eye diseases.
North America Ophthalmology Devices Market Revenue and Forecast to 2031 (US$ Million)
North America Ophthalmology Devices Market Segmentation
The North America ophthalmology devices market is segmented based on product, application, end user, and country.
Based on product, the North America ophthalmology devices market is segmented into vision care products, surgical devices, and diagnostics and monitoring devices. The vision care products segment held the largest share in 2023.
In terms of application, the North America ophthalmology devices market is segmented into cataract, glaucoma, refractory disorders, vitreoretinal disorders, and other applications. The glaucoma segment held the largest share in 2023.
By end user, the North America ophthalmology devices market is segmented into hospital and eye clinics, academic and research laboratories, and other end users. The hospital and eye clinics segment held the largest share in 2023.
Based on country, the North America ophthalmology devices market is categorized into US, Canada, and Mexico. The US dominated the North America ophthalmology devices market in 2023.
Key players operating in the North America ophthalmology devices market are Johnson & Johnson Vision Care Inc, Alcon AG, Carl Zeiss Meditec, Bausch & Lomb Inc, Essilor Intonational SAS, Nidek Co Ltd, Topcon Corp, Haag-Streit AG, Ziemer Ophthalmic Systems AG, and Hoya Corp are some of the leading companies operating in the North America ophthalmology devices market.